SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-015253
Filing Date
2018-06-07
Accepted
2018-06-07 17:05:40
Documents
58
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ubx-10q_20180331.htm 10-Q 1811454
2 EX-31.1 ubx-ex311_9.htm EX-31.1 19631
3 EX-31.2 ubx-ex312_8.htm EX-31.2 19614
4 EX-32.1 ubx-ex321_7.htm EX-32.1 14456
  Complete submission text file 0001564590-18-015253.txt   6506687

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ubx-20180331.xml EX-101.INS 1469307
6 XBRL TAXONOMY EXTENSION SCHEMA ubx-20180331.xsd EX-101.SCH 45534
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ubx-20180331_cal.xml EX-101.CAL 39901
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ubx-20180331_def.xml EX-101.DEF 157248
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ubx-20180331_lab.xml EX-101.LAB 340653
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ubx-20180331_pre.xml EX-101.PRE 268936
Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005 (415) 328-5504
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38470 | Film No.: 18887223
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1